99 related articles for article (PubMed ID: 2620541)
1. Immunohistochemical analysis of accelerated graft atherosclerosis in cardiac transplantation.
Louie HW; Pang M; Lewis W; Drinkwater DC; Laks H
Curr Surg; 1989; 46(6):479-83. PubMed ID: 2620541
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis.
Cramer DV; Wu GD; Chapman FA; Cajulis E; Wang HK; Makowka L
J Heart Lung Transplant; 1992; 11(3 Pt 1):458-66. PubMed ID: 1610855
[TBL] [Abstract][Full Text] [Related]
3. [Immunocytochemical investigations of cardiac and vessel allograft arteriosclerosis using smooth muscle cell and macrophage-specific monoclonal antibodies].
Sasaguri S
Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1840-7. PubMed ID: 2608013
[TBL] [Abstract][Full Text] [Related]
4. Chronic rejection in experimental cardiac transplantation in a rat model.
Karnovsky MJ; Russell ME; Hancock W; Sayegh MH; Adams DH
Clin Transplant; 1994 Jun; 8(3 Pt 2):308-12. PubMed ID: 8061372
[TBL] [Abstract][Full Text] [Related]
5. [Circulating recipient cells contribute to graft coronary arteriosclerosis].
Sata M; Hirata Y; Nagai R
J Cardiol; 2002 Jan; 39(1):48-9. PubMed ID: 11828797
[TBL] [Abstract][Full Text] [Related]
6. Morphometric and immunocytochemical analysis of coronary arterioles in human transplanted hearts.
Armstrong AT; Strauch AR; Kardan A; Starling RC
J Heart Lung Transplant; 1996 Aug; 15(8):818-26. PubMed ID: 8878764
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
Rabinovitch M; Molossi S; Clausell N
J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
[No Abstract] [Full Text] [Related]
8. Cytomegalovirus infection induces vascular wall inflammation and doubles arteriosclerotic changes in rat cardiac allografts.
Koskinen P; Lemström K; Bruning H; Daemen M; Bruggeman C; Häyry P
Transplant Proc; 1995 Feb; 27(1):574-5. PubMed ID: 7879104
[No Abstract] [Full Text] [Related]
9. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of graft coronary arteriosclerosis after heart transplantation.
Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
[TBL] [Abstract][Full Text] [Related]
11. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
[TBL] [Abstract][Full Text] [Related]
12. Contribution of mesenchymal progenitor cells to tissue repair in rat cardiac allografts undergoing chronic rejection.
Wu GD; Bowdish ME; Jin YS; Zhu H; Mitsuhashi N; Barsky LW; Barr ML
J Heart Lung Transplant; 2005 Dec; 24(12):2160-9. PubMed ID: 16364866
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
[TBL] [Abstract][Full Text] [Related]
14. Role of selectin-dependent adhesion in cardiac allograft rejection.
Yamazaki S; Isobe M; Suzuki J; Tojo S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1998 Oct; 17(10):1007-16. PubMed ID: 9811410
[TBL] [Abstract][Full Text] [Related]
15. Endothelialitis and accelerated arteriosclerosis in human heart transplant coronaries.
Paavonen T; Mennander A; Lautenschlager I; Mattila S; Häyry P
J Heart Lung Transplant; 1993; 12(1 Pt 1):117-22. PubMed ID: 8382949
[TBL] [Abstract][Full Text] [Related]
16. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
Bouchard D; Despatis MA; Buluran J; Cartier R
Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
[TBL] [Abstract][Full Text] [Related]
18. Modulation of inflammatory activation pathways in the Lewis-to-F-344 rat chronic cardiac rejection model.
Russell ME; Hancock WW; Wallace AF; Wyner LR; Karnovsky MJ
Transplant Proc; 1995 Jun; 27(3):2100-4. PubMed ID: 7792898
[No Abstract] [Full Text] [Related]
19. Altered expression of smooth muscle and non-muscle myosin heavy chain isoforms in rejected hearts: a sensitive marker for acute rejection and graft coronary arteriosclerosis.
Suzuki J; Aikawa M; Isobe M; Sekiguchi M; Yazaki Y; Nagai R
Transplant Proc; 1995 Feb; 27(1):578. PubMed ID: 7879106
[No Abstract] [Full Text] [Related]
20. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
Richter MH; Richter HR; Olbrich HG; Mohr FW
Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
